2024-02-012025-01-312025-01-31false07430397MEDS AT HOME LIMITED2025-10-03falseiso4217:GBPxbrli:pure074303972024-01-31074303972025-01-31074303972024-02-012025-01-31074303972023-01-31074303972024-01-31074303972023-02-012024-01-3107430397bus:SmallEntities2024-02-012025-01-3107430397bus:AuditExempt-NoAccountantsReport2024-02-012025-01-3107430397bus:FullAccounts2024-02-012025-01-3107430397bus:PrivateLimitedCompanyLtd2024-02-012025-01-3107430397core:WithinOneYear2025-01-3107430397core:AfterOneYear2025-01-3107430397core:WithinOneYear2024-01-3107430397core:AfterOneYear2024-01-3107430397core:ShareCapital2025-01-3107430397core:SharePremium2025-01-3107430397core:RevaluationReserve2025-01-3107430397core:OtherReservesSubtotal2025-01-3107430397core:RetainedEarningsAccumulatedLosses2025-01-3107430397core:ShareCapital2024-01-3107430397core:SharePremium2024-01-3107430397core:RevaluationReserve2024-01-3107430397core:OtherReservesSubtotal2024-01-3107430397core:RetainedEarningsAccumulatedLosses2024-01-3107430397core:LandBuildings2025-01-3107430397core:PlantMachinery2025-01-3107430397core:Vehicles2025-01-3107430397core:FurnitureFittings2025-01-3107430397core:OfficeEquipment2025-01-3107430397core:NetGoodwill2025-01-3107430397core:IntangibleAssetsOtherThanGoodwill2025-01-3107430397core:ListedExchangeTraded2025-01-3107430397core:UnlistedNon-exchangeTraded2025-01-3107430397core:LandBuildings2024-01-3107430397core:PlantMachinery2024-01-3107430397core:Vehicles2024-01-3107430397core:FurnitureFittings2024-01-3107430397core:OfficeEquipment2024-01-3107430397core:NetGoodwill2024-01-3107430397core:IntangibleAssetsOtherThanGoodwill2024-01-3107430397core:ListedExchangeTraded2024-01-3107430397core:UnlistedNon-exchangeTraded2024-01-3107430397core:LandBuildings2024-02-012025-01-3107430397core:PlantMachinery2024-02-012025-01-3107430397core:Vehicles2024-02-012025-01-3107430397core:FurnitureFittings2024-02-012025-01-3107430397core:OfficeEquipment2024-02-012025-01-3107430397core:NetGoodwill2024-02-012025-01-3107430397core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3107430397core:ListedExchangeTraded2024-02-012025-01-3107430397core:UnlistedNon-exchangeTraded2024-02-012025-01-3107430397core:MoreThanFiveYears2024-02-012025-01-3107430397core:Non-currentFinancialInstruments2025-01-3107430397core:Non-currentFinancialInstruments2024-01-3107430397dpl:CostSales2024-02-012025-01-3107430397dpl:DistributionCosts2024-02-012025-01-3107430397core:LandBuildings2024-02-012025-01-3107430397core:PlantMachinery2024-02-012025-01-3107430397core:Vehicles2024-02-012025-01-3107430397core:FurnitureFittings2024-02-012025-01-3107430397core:OfficeEquipment2024-02-012025-01-3107430397dpl:AdministrativeExpenses2024-02-012025-01-3107430397core:NetGoodwill2024-02-012025-01-3107430397core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3107430397dpl:GroupUndertakings2024-02-012025-01-3107430397dpl:ParticipatingInterests2024-02-012025-01-3107430397dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3107430397core:ListedExchangeTraded2024-02-012025-01-3107430397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3107430397core:UnlistedNon-exchangeTraded2024-02-012025-01-3107430397dpl:CostSales2023-02-012024-01-3107430397dpl:DistributionCosts2023-02-012024-01-3107430397core:LandBuildings2023-02-012024-01-3107430397core:PlantMachinery2023-02-012024-01-3107430397core:Vehicles2023-02-012024-01-3107430397core:FurnitureFittings2023-02-012024-01-3107430397core:OfficeEquipment2023-02-012024-01-3107430397dpl:AdministrativeExpenses2023-02-012024-01-3107430397core:NetGoodwill2023-02-012024-01-3107430397core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3107430397dpl:GroupUndertakings2023-02-012024-01-3107430397dpl:ParticipatingInterests2023-02-012024-01-3107430397dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3107430397core:ListedExchangeTraded2023-02-012024-01-3107430397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3107430397core:UnlistedNon-exchangeTraded2023-02-012024-01-3107430397core:NetGoodwill2025-01-3107430397core:IntangibleAssetsOtherThanGoodwill2025-01-3107430397core:LandBuildings2025-01-3107430397core:PlantMachinery2025-01-3107430397core:Vehicles2025-01-3107430397core:FurnitureFittings2025-01-3107430397core:OfficeEquipment2025-01-3107430397core:AfterOneYear2025-01-3107430397core:WithinOneYear2025-01-3107430397core:ListedExchangeTraded2025-01-3107430397core:UnlistedNon-exchangeTraded2025-01-3107430397core:ShareCapital2025-01-3107430397core:SharePremium2025-01-3107430397core:RevaluationReserve2025-01-3107430397core:OtherReservesSubtotal2025-01-3107430397core:RetainedEarningsAccumulatedLosses2025-01-3107430397core:NetGoodwill2024-01-3107430397core:IntangibleAssetsOtherThanGoodwill2024-01-3107430397core:LandBuildings2024-01-3107430397core:PlantMachinery2024-01-3107430397core:Vehicles2024-01-3107430397core:FurnitureFittings2024-01-3107430397core:OfficeEquipment2024-01-3107430397core:AfterOneYear2024-01-3107430397core:WithinOneYear2024-01-3107430397core:ListedExchangeTraded2024-01-3107430397core:UnlistedNon-exchangeTraded2024-01-3107430397core:ShareCapital2024-01-3107430397core:SharePremium2024-01-3107430397core:RevaluationReserve2024-01-3107430397core:OtherReservesSubtotal2024-01-3107430397core:RetainedEarningsAccumulatedLosses2024-01-3107430397core:NetGoodwill2023-01-3107430397core:IntangibleAssetsOtherThanGoodwill2023-01-3107430397core:LandBuildings2023-01-3107430397core:PlantMachinery2023-01-3107430397core:Vehicles2023-01-3107430397core:FurnitureFittings2023-01-3107430397core:OfficeEquipment2023-01-3107430397core:AfterOneYear2023-01-3107430397core:WithinOneYear2023-01-3107430397core:ListedExchangeTraded2023-01-3107430397core:UnlistedNon-exchangeTraded2023-01-3107430397core:ShareCapital2023-01-3107430397core:SharePremium2023-01-3107430397core:RevaluationReserve2023-01-3107430397core:OtherReservesSubtotal2023-01-3107430397core:RetainedEarningsAccumulatedLosses2023-01-3107430397core:AfterOneYear2024-02-012025-01-3107430397core:WithinOneYear2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:CostValuation2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3107430397core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3107430397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3107430397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3107430397bus:Director12024-02-012025-01-3107430397bus:Director22024-02-012025-01-31

MEDS AT HOME LIMITED

Registered Number
07430397
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2025

MEDS AT HOME LIMITED
Company Information
for the year from 1 February 2024 to 31 January 2025

Directors

HUSSAIN, Ashraf
IQBAL, Amjid

Registered Address

Unit 26 Delph Industrial Estate, Delph Road
Brierley Hill
DY5 2UA

Registered Number

07430397 (England and Wales)
MEDS AT HOME LIMITED
Balance Sheet as at
31 January 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,372278
1,372278
Current assets
Stocks438,48136,847
Debtors5175,697168,241
Cash at bank and on hand9,91915,250
224,097220,338
Creditors amounts falling due within one year6(154,143)(168,432)
Net current assets (liabilities)69,95451,906
Total assets less current liabilities71,32652,184
Net assets71,32652,184
Capital and reserves
Called up share capital100100
Profit and loss account71,22652,084
Shareholders' funds71,32652,184
The financial statements were approved and authorised for issue by the Board of Directors on 3 October 2025, and are signed on its behalf by:
HUSSAIN, Ashraf
Director
IQBAL, Amjid
Director

Registered Company No. 07430397
MEDS AT HOME LIMITED
Notes to the Financial Statements
for the year ended 31 January 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year810
3.Tangible fixed assets

Land & buildings

Plant & machinery

Office Equipment

Total

££££
Cost or valuation
At 01 February 241,86837,19641,90380,967
Additions--1,4001,400
At 31 January 251,86837,19643,30382,367
Depreciation and impairment
At 01 February 241,86837,19641,62580,689
Charge for year--306306
At 31 January 251,86837,19641,93180,995
Net book value
At 31 January 25--1,3721,372
At 31 January 24--278278
4.Stocks

2025

2024

££
Raw materials and consumables38,48136,847
Total38,48136,847
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables153,754144,516
Other debtors17,32820,554
Prepayments and accrued income4,6153,171
Total175,697168,241
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables90,34985,037
Taxation and social security6,3822,786
Payments received on account49,32669,848
Other creditors8,08610,761
Total154,143168,432
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.